canertinib has been researched along with thalidomide in 1 studies
| Studies (canertinib) | Trials (canertinib) | Recent Studies (post-2010) (canertinib) | Studies (thalidomide) | Trials (thalidomide) | Recent Studies (post-2010) (thalidomide) |
|---|---|---|---|---|---|
| 124 | 9 | 65 | 9,789 | 1,385 | 4,342 |
| Protein | Taxonomy | canertinib (IC50) | thalidomide (IC50) |
|---|---|---|---|
| Cereblon isoform 4 | Magnetospirillum gryphiswaldense | 7.8 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.37 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 0.5 | |
| DNA damage-binding protein 1 | Homo sapiens (human) | 1.38 | |
| Protein cereblon | Homo sapiens (human) | 1.38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, B; Liu, H; Qiu, X; Qu, X; Song, X; Sun, N; Yang, X; Zhong, H | 1 |
1 other study(ies) available for canertinib and thalidomide
| Article | Year |
|---|---|
Effective degradation of EGFR
Topics: Apoptosis; Autophagy; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Lysosomes; Molecular Structure; Morpholines; Mutation; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Structure-Activity Relationship; Thalidomide | 2021 |